Effect of adalimumab on axial manifestations in Japanese patients with psoriatic arthritis: a 24 week prospective, observational study.
Takamitsu MakinoHironobu IhnMotoo NakagawaMisugi UranoRyuhei OkuyamaNorito KatohChiharu TateishiKoji MasudaEisaku OgawaEmi NishidaShohei NishimotoKenzo MuramotoDaisuke TsurutaAkimichi MoritaPublished in: Rheumatology (Oxford, England) (2021)
Treatment with adalimumab for 24 weeks resulted in improvement in spondylitis and sacroiliitis.